Top-level promotions at Saatchi & Saatchi Healthcare

Share this article:
Publicis Healthcare Communications Group’s (PHCG) has announced the promotions of Sam Welch to president of its Saatchi & Saatchi Healthcare Communications (SSHC) group and Dave Marek as SSHC’s managing director. Welch will report directly to Mike Trepicchio, who was named PHCG’s president, North American advertising last month. Welch, most recently served as managing director for SSHC’s Saatchi & Saatchi Healthcare Advertising unit. He joined SSHC, formerly known as Klemtner, more than 10 years ago, as VP, account group supervisor for the agency’s Prilosec business. Marek, who will report directly to Welch, joined Klemtner six years ago as VP, account group director for Enbrel.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...